Streetbeat News

Regulatory

PHRRF

The FDA has accepted PharmaTher Holdings' (OTCQB:PHRRF) new drug application for a racemic ketamine product, KETARX. The goal date for the drug is April 29, 2024. PharmaTher anticipates KETARX’s U.S. commercial launch and the pursuit of international approvals thereafter. The company plans to commercialize KETARX in several dosage forms in the U.S. through its partnership with Vitruvias Therapeutics.

Portfolio Pulse from Lara Goldstein

September 27, 2023 | 6:38 pm

SPY

Senate Majority Leader Mitch McConnell has expressed his comfort with the Senate spending bill, according to Reuters. This could potentially lead to a smoother legislative process and reduce political uncertainty.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:36 pm

JBLU

SAVE

Democratic Senator Elizabeth Warren has raised concerns about JetBlue's acquisition of Spirit Airlines, citing leaked court documents. She is seeking clarification on whether the deal will lead to higher fares for consumers.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:23 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers has expressed optimism about the language of Florida's legalization legislature. The company is currently awaiting a decision from the state Supreme Court.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:20 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers stated that it will take some time for the company's initiatives to move through the House. The statement was made during a Benzinga subscriber event.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:18 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers has described the vote in the Senate today as a 'historic day'. The news was reported by Benzinga, a financial news outlet.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:17 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers stated that the vote today was as expected and the company's focus will still be on Section 10. She also mentioned that Schumer's immediate support is a positive sign.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:16 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers has expressed expectations for the rescheduling of cannabis 'sooner rather than later'.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:13 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers anticipates a surge of bills following the SAFER Banking Act vote. The statement was made during a Benzinga conference.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:12 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers announced that the company has paid approximately $223M in taxes to the Federal Government as a result of the 280 tax code.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:11 pm